Overview

Diuretics In the Management of Essential Hypertension (DIME) Study

Status:
Completed
Trial end date:
2013-11-01
Target enrollment:
Participant gender:
Summary
The purpose of DIME is to evaluate the safety (i.e. new onset of diabetes and other metabolic adverse events), efficacy and cost-effectiveness of antihypertensive treatment with low dose diuretics. The researchers' hypothesis is that use of low dose thiazide diuretics is metabolically safe when used with other appropriate antihypertensives, effective in reduction of blood pressure and cheaper than treatment without diuretics. Therefore, this study is an equivalence trial.
Phase:
Phase 4
Details
Lead Sponsor:
Kyoto University
Collaborator:
University of the Ryukyus
Treatments:
Diuretics
Sodium Chloride Symporter Inhibitors